MCRI Gets Go-Ahead To Study Reduced Anticoagulation Therapy With Valves
This article was originally published in The Gray Sheet
Executive Summary
The Medical Carbon Research Institute has received the first investigational device exemption from FDA to study whether a mechanical heart valve can be indicated for use with reduced levels of anticoagulants